"Muscles keep their strength after substantial weight loss following treatment with the new generation of obesity drugs."
GLP-1 receptor agonist medications, a new generation of obesity drugs, enable significant weight loss while maintaining muscle mass and strength. Research demonstrates that muscle mass either increased or remained stable relative to body weight in both middle-aged mice and humans treated with these drugs. This finding is particularly important because traditional weight loss often results in muscle loss alongside fat loss. The preservation of muscle strength during GLP-1 treatment suggests these medications may offer metabolic advantages beyond simple caloric reduction, potentially maintaining physical function and metabolic health during weight loss.
Read at Nature
Unable to calculate read time
Collection
[
|
...
]